Fennec Pharmaceuticals Inc.FENCNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-7.99M
↓ 16% vs avg
Percentile
P33
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-6.87M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-7.99M | -129.6% |
| 2024 | $26.98M | +257.4% |
| 2023 | $-17.14M | +5.1% |
| 2022 | $-18.06M | -27.0% |
| 2021 | $-14.22M | +8.8% |
| 2020 | $-15.60M | -72.1% |
| 2019 | $-9.06M | -15.8% |
| 2018 | $-7.83M | -114.9% |
| 2017 | $-3.64M | -71.4% |
| 2016 | $-2.12M | - |